Toyota|$17.90 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$25.06 (¥3,959)+1.93%▲ (in JPY terms)
SoftBank|$31.29 (¥4,944)+1.90%▲ (in JPY terms)
MUFG|$22.00 (¥3,475)+1.82%▲ (in JPY terms)
Keyence|$511.18 (¥80,760)+2.27%▲ (in JPY terms)
Nintendo|$53.67 (¥8,479)+3.05%▲ (in JPY terms)
NTT|$1.10 (¥175)+0.69%▲ (in JPY terms)
Takeda|$39.39 (¥6,223)+0.65%▲ (in JPY terms)
Tokyo Electron|$67.28 (¥10,630)+2.56%▲ (in JPY terms)
Recruit|$116.59 (¥18,420)+0.22%▲ (in JPY terms)
ITOCHU|$14.46 (¥2,284)+2.84%▲ (in JPY terms)
Honda|$11.38 (¥1,798)+1.21%▲ (in JPY terms)
Shin-Etsu|$37.84 (¥5,978)+0.25%▲ (in JPY terms)
Tokio Marine|$3.53 (¥558)+2.89%▲ (in JPY terms)
Fast Retailing|$478.39 (¥75,580)-1.07%▼ (in JPY terms)
Toyota|$17.90 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$25.06 (¥3,959)+1.93%▲ (in JPY terms)
SoftBank|$31.29 (¥4,944)+1.90%▲ (in JPY terms)
MUFG|$22.00 (¥3,475)+1.82%▲ (in JPY terms)
Keyence|$511.18 (¥80,760)+2.27%▲ (in JPY terms)
Nintendo|$53.67 (¥8,479)+3.05%▲ (in JPY terms)
NTT|$1.10 (¥175)+0.69%▲ (in JPY terms)
Takeda|$39.39 (¥6,223)+0.65%▲ (in JPY terms)
Tokyo Electron|$67.28 (¥10,630)+2.56%▲ (in JPY terms)
Recruit|$116.59 (¥18,420)+0.22%▲ (in JPY terms)
ITOCHU|$14.46 (¥2,284)+2.84%▲ (in JPY terms)
Honda|$11.38 (¥1,798)+1.21%▲ (in JPY terms)
Shin-Etsu|$37.84 (¥5,978)+0.25%▲ (in JPY terms)
Tokio Marine|$3.53 (¥558)+2.89%▲ (in JPY terms)
Fast Retailing|$478.39 (¥75,580)-1.07%▼ (in JPY terms)

JP3475350009

2026-05-25 DAIICHI SANKYO COMPANY,LIMITED “The PDF file (311.8KB) regarding the partial amendment approval of Datroway® (datopotamab deruxtecan) for the first-line treatment of triple-negative breast cancer in the United States will open in a new window.”

by

2026-05-25 DAIICHI SANKYO COMPANY,LIMITED “The PDF file (311.8KB) regarding the partial amendment approv … 続きを読む

2026-05-18 DAIICHI SANKYO COMPANY,LIMITED “The PDF file (277.7KB) regarding the approval of two partial changes to the Enhertu® (trastuzumab deruxtecan) drug for HER2-positive early-stage breast cancer in the United States will open in a new window.”

by

2026-05-18 DAIICHI SANKYO COMPANY,LIMITED “The PDF file (277.7KB) regarding the approval of two partial … 続きを読む

2026-05-11 DAIICHI SANKYO COMPANY,LIMITED “Notice of manufacturing and marketing approval in Japan for the dried attenuated live measles, mumps, and rubella combined vaccine "Mimlit® for subcutaneous injection" (176.8KB). (PDF file will open in a new window.)”

by

2026-05-11 DAIICHI SANKYO COMPANY,LIMITED “Notice of manufacturing and marketing approval in Japan for t … 続きを読む

2026-05-08 DAIICHI SANKYO COMPANY,LIMITED “A PDF file (292.3KB) regarding losses incurred due to a revision of the product supply plan and revisions to the consolidated earnings forecast for the full fiscal year ending March 2026 will be displayed in a new window.”

by

2026-05-08 DAIICHI SANKYO COMPANY,LIMITED “A PDF file (292.3KB) regarding losses incurred due to a revis … 続きを読む

2026-03-09 DAIICHI SANKYO COMPANY,LIMITED “Submission of partial amendment for approval of trastuzumab deruxtecan (T-DXd/DS-8201) for HER2-positive breast cancer following neoadjuvant therapy in the United States (242.9 KB) PDF file opens in a new window.”

by

2026-03-09 DAIICHI SANKYO COMPANY,LIMITED “Submission of partial amendment for approval of trastuzumab d … 続きを読む

Contact